Sample Headlines and Articles from Zacks

Zacks Investment Research - All Commentary Articles

Janux Therapeutics, Inc. (JANX) Moves 5.6% Higher: Will This Strength Last? (Wed, 21 Feb 2024)
Janux Therapeutics, Inc. (JANX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
>> Read more

DecisionPoint Systems Inc. (DPSI) Surges 5.3%: Is This an Indication of Further Gains? (Wed, 21 Feb 2024)
DecisionPoint Systems Inc. (DPSI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
>> Read more

Matador (MTDR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Tue, 20 Feb 2024)
The headline numbers for Matador (MTDR) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
>> Read more

EnLink Midstream (ENLC) Reports Q4 Earnings: What Key Metrics Have to Say (Tue, 20 Feb 2024)
Although the revenue and EPS for EnLink Midstream (ENLC) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
>> Read more

Workiva (WK) Reports Q4 Earnings: What Key Metrics Have to Say (Tue, 20 Feb 2024)
While the top- and bottom-line numbers for Workiva (WK) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
>> Read more

WillScot (WSC) Reports Q4 Earnings: What Key Metrics Have to Say (Tue, 20 Feb 2024)
Although the revenue and EPS for WillScot (WSC) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
>> Read more

Skyward (SKWD) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Tue, 20 Feb 2024)
Although the revenue and EPS for Skyward (SKWD) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
>> Read more

Redwood Trust (RWT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Tue, 20 Feb 2024)
While the top- and bottom-line numbers for Redwood Trust (RWT) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
>> Read more

Consumer Discretionary ETF (FXD) Hits New 52-Week High (Tue, 20 Feb 2024)
The Consumer Discretionary ETF hit a 52-week high lately. Can it soar higher?
>> Read more

Beyond (BYON) Reports Q4 Loss, Tops Revenue Estimates (Tue, 20 Feb 2024)
Beyond (BYON) delivered earnings and revenue surprises of -71.83% and 12.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
>> Read more

Teladoc (TDOC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Tue, 20 Feb 2024)
The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
>> Read more

Sprout Social (SPT) Reports Q4 Earnings: What Key Metrics Have to Say (Tue, 20 Feb 2024)
The headline numbers for Sprout Social (SPT) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
>> Read more